RFG
UTHR icon

RFP Financial Group’s United Therapeutics UTHR Stock Holding History

RFP Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$956 – 766
2024
Q2 		$956 Hold
3
– – ﹤0.01% 811
2024
Q1 		$689 Hold
3
– – ﹤0.01% 794
2023
Q4 		$660 Sell
3
-29
-91% -$6.68K ﹤0.01% 819
2023
Q3 		$7.23K Hold
32
– – ﹤0.01% 445
2023
Q2 		$7.06K Hold
32
– – ﹤0.01% 486
2023
Q1 		$7.17K Hold
32
– – 0.01% 333
2022
Q4 		$8.9K Buy
+32
New +$8.08K ﹤0.01% 407

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RFP Financial Group's UTHR Position: Q3 2024 in Review

RFP Financial Group sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 3 shares — an estimated $956 sold.

RFP Financial Group first reported a position in UTHR in Q4 2022 and held it in 7 quarters. The position peaked at $8.9K in Q4 2022. 625 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • RFP Financial Group reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 3 United Therapeutics shares in Q3 2024, an estimated $956.
  • RFP Financial Group first reported a position in United Therapeutics in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's United Therapeutics position peaked at $8.9K in Q4 2022.
  • 625 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.